Literature DB >> 9187981

The effect of a home-based, case-managed, multifactorial risk-reduction program on reducing psychological distress in patients with cardiovascular disease.

C B Taylor1, N H Miller, P M Smith, R F DeBusk.   

Abstract

BACKGROUND: This study examined the effects of a nurse-case-managed, multifactorial, risk-reduction program on psychological distress among patients after myocardial infarction (MI).
METHODS: Five hundred eighty-five men and women aged 70 years or younger, who were hospitalized for acute MI in one of five San Francisco Bay Area hospitals, were randomized to receive a nurse-managed, home-based, multifactorial risk-reduction program (n = 293) or usual care (n = 292). The program, which began in the hospital, included a brief screen for five areas of psychological distress with further evaluation if indicated, monitoring during the follow-up phone calls, and referral for mental health treatment if needed. Patients were assessed with single-item scales at baseline, and at 6 and 12 months. Separate analyses were performed for patients with moderate-to-severe levels on the psychological distress domains and for those with low levels.
RESULTS: There was a significant reduction in the psychological distress variables for all patient groups between baseline and 12 months. The program had a significant effect on reducing anxiety in the patient group with low levels of anxiety and reducing anger in the patient group with frequent episodes of anger but, overall, the treatment and control groups showed equal levels of improvement.
CONCLUSION: Among patients post-MI without complications, psychological distress decreases significantly during the 12 months after MI.

Entities:  

Mesh:

Year:  1997        PMID: 9187981     DOI: 10.1097/00008483-199705000-00002

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  11 in total

1.  Cardiac rehabilitation.

Authors:  J Dinnes; J Kleijnen; M Leitner; D Thompson
Journal:  Qual Health Care       Date:  1999-03

Review 2.  AAFP guideline for the detection and management of post-myocardial infarction depression.

Authors: 
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

Review 3.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Balraj S Heran; Jenny Mh Chen; Shah Ebrahim; Tiffany Moxham; Neil Oldridge; Karen Rees; David R Thompson; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

4.  Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review.

Authors:  Julia M Farquhar; Gregory L Stonerock; James A Blumenthal
Journal:  Psychosomatics       Date:  2018-03-27       Impact factor: 2.386

Review 5.  Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home.

Authors:  P Mistiaen; E Poot
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 6.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Grace Dibben; James Faulkner; Neil Oldridge; Karen Rees; David R Thompson; Ann-Dorthe Zwisler; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2021-11-06

Review 7.  Heart and mind: (1) relationship between cardiovascular and psychiatric conditions.

Authors:  S U Shah; A White; S White; W A Littler
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

Review 8.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Lindsey Anderson; David R Thompson; Neil Oldridge; Ann-Dorthe Zwisler; Karen Rees; Nicole Martin; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2016-01-05

Review 9.  Psychological interventions for coronary heart disease.

Authors:  K Rees; P Bennett; R West; Smith G Davey; S Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Omissions impact measurements of patient-reported outcomes.

Authors:  Frans Pouwer
Journal:  Qual Life Res       Date:  2008-05-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.